Sign in

CIK 0001844417 · <br>Emerging growth company

Estrella Immunopharma, Inc.

Sign in to watch
Ticker
ESLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
861314502
Phone
(510) 318-9098
Business address
5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
Former names
TradeUP Acquisition Corp.

Securities

  • ESLA Common Stock Nasdaq
  • ESLAW Warrant Nasdaq
  1. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  2. 10-Q Report Quarterly Report
  3. 10-K Report Annual Report
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 4 Open-market buy Co-Chief Executive Officer bought 141,970 shares at $314,700.00 ($44,677,959,000)
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. SC 13G Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. 10-Q Report Quarterly Report
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G Stake Amended Statement of Ownership
  13. 8-K Event Other events
  14. SC 13G/A Stake Amended Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. SC 13G Stake Amended Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 11 of 13 · 258 filings